Evidence Corner
Welcome to Evidence Corner. Here we try to explain the data behind the clinical decisions we make through deep-diving studies that have shaped how we treat patients with liver disease. For each clinical question, we’ve chosen a single study and with our digestible slides, we try to concisely highlight the key aspects of the study.
Current Team
Fellow Lead
Faculty Editor
Evidence CornerCan COVID-19 vaccination improve outcomes for patients with chronic liver disease or post-liver transplant in those who contract the infection?
Learn how covid-19 vaccination affects outcomes in patients with liver disease
Chiara MaruggiEvidence CornerDoes the stage of fibrosis predict outcomes in NAFLD?
Does the stage of fibrosis predict outcomes in NAFLD?
Richie ManikatEvidence CornerAre there any differences in mortality and liver transplant rates across race in patients with cirrhosis?
https://pubmed.ncbi.nlm.nih.gov/34128254/
Nabeel WahidEvidence CornerHow can we most accurately predict post-operative mortality for patients with cirrhosis? The VOCAL-Penn score is here to help!
Ever received a consult about surgical risk stratification for a patient with cirrhosis. The VOCAL-Penn score tried to help most accurately predict the answer. The…
Alex VogelEvidence CornerWhat is MELD 3.0 and how might it better predict waitlist mortality than MELD-Na?
Heard about MELD 3.0 but not sure how it differs from MELD-Na? This is the paper that explains what MELD 3.0 is and how it…
Nabeel WahidEvidence CornerMedical Therapies in Alagille Syndrome
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study – ScienceDirect Continuing on with…
Sindhu PandurangiEvidence CornerWhat regimens are most effective for induction and maintenance therapy for patients with autoimmune hepatitis?
If you were ever wondering why certain regimens are used in the treatment of AIH, here is the meta-analysis that helped determine the most effective…
Alex VogelEvidence CornerShould HBV genotype be considered in determining who to surveil for HCC?
In patients with chronic HBV infection, should HBV genotype be considered when determining who should undergo HCC surveillance? This trial tries to answer just that…
Muyi LiEvidence CornerIs bariatric surgery an effective and safe management for NASH?
If you are curious if bariatric surgery is safe and effective in patients with NASH, this is the study for you. https://jamanetwork.com/journals/jama/article-abstract/2786270
Chiara MaruggiEvidence CornerCan kids become operationally tolerant after transplant?
Children are not small adults and thus their immune system is much more sophisticated… Check out the seminal iWITH trial establishing that in selected pediatric…
Tamir DiamondCurrent Team
Fellow Lead
Faculty Editor
Ideas?
Do you have suggestions for topics within this series? Are you a fellow interested in contributing? Please feel free to reach out via Twitter to the fellow lead or to Liver Fellow Network directly. You can also e-mail us at liverfellownetwork@gmail.com.